Rare diseases and recognizing heroes: Oxford PharmaGenesis sponsors the latest CISCRP Clinical Trials supplement

14 December 2021

Share this page

Share this page on LinkedIn

Oxford PharmaGenesis is proud to sponsor the CISCRP December 2021 Clinical Trials supplement, which raises awareness of rare diseases and neurology, and celebrates the millions of people who volunteer for clinical trials each year.

CISCRP (Center for Information and Study on Clinical Research Participation) is an established leader in the area of patient engagement. Based in the USA, this non-profit organization implements large-scale educational media campaigns throughout the year to build clinical trial awareness within diverse patient communities and among the general public.

The December 2021 supplement will be distributed in USA Today. It includes a feature in which a husband and wife patient-and-caregiver team shares their experience of a rare disease clinical trial. It also recognizes and celebrates all participants in clinical trials – from volunteers to researchers to medical professionals ­– for their help in advancing knowledge about disease and improving medicine for the future.

Oxford PharmaGenesis COO Richard White says:

“CISCRP’s mission, and the themes of this supplement, closely align with our own work. As a HealthScience communications consultancy with broad areas of interest, we have a strong heritage in the field of rare diseases.

“It’s critical that we discover medical treatments that are effective for people of all backgrounds. With CISCRP, we want to say a big thank you to everyone involved in the clinical trials process. Every single person is equally important and makes an invaluable contribution. Together, we’ll shape the future of medical care.”

Oxford PharmaGenesis has a longstanding collaborative relationship with CISCRP, previously sponsoring a supplement in June that honoured ‘Medical Heroes’, as well as sponsoring campaigns in May and October.

The sponsorship also builds on the ongoing commitment of Oxford PharmaGenesis to equality, diversity and inclusion; working in partnership with colleagues on the topics that matter to them, while maintaining and evolving our ‘great place to work’ ethos and compassionate culture.

We invite you to join us in helping to inform the public about the importance of diversity among study volunteers who participate in clinical research. View the campaign and supplement here.